Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Tutwiler

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Comparative Biochemistry and Physiology. A, Comparative Physiology|April 1, 1975
Immunological cross-reaction of bovine growth hormone (NIH-GH-B8) with the antiserum to the bovine diabetogenic proteinG F Tutwiler
Experientia|November 15, 1973
Hypoglycemic activity of alpha-bromopalmitate in ratsG F Tutwiler
Biochemical Medicine|October 1, 1979
Effect of the oral hypoglycemic agent, pirogliride, on lipolysisG F Tutwiler
Biochimica Et Biophysica Acta|September 8, 1975
In vitro lipolytic effect of bovine pituitary diabetogenic proteinG F Tutwiler
Acta Diabetologica Latina|September 1, 1976
Diabetogenic activity of the anterior pituitary (a progress report)G F Tutwiler
Research Communications in Chemical Pathology and Pharmacology|March 1, 1978
Effects of phenformin and alpha-bromopalmitate on fatty acid and glucose oxidation in muscleG F Tutwiler
Comparative Biochemistry and Physiology. A, Comparative Physiology|April 1, 1975
Immunological characterization of a diabetogenic protein from bovine adenohypophysisG F Tutwiler
Biochemistry International|July 1, 1983
Effect of the oral hypoglycemic agent pirogliride (McN-3495) on glycogen levels of normal and diabetic ratsG F Tutwiler, H Fawthrop
The Journal of Biological Chemistry|April 25, 1979
Action of the oral hypoglycemic agent 2-tetradecylglycidic acid on hepatic fatty acid oxidation and gluconeogenesisG F Tutwiler, P Dellevigne
Diabetes|August 1, 1978
Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanidesG F Tutwiler, G Bridi
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Comparative Biochemistry and Physiology. A, Comparative Physiology|April 1, 1975
Immunological cross-reaction of bovine growth hormone (NIH-GH-B8) with the antiserum to the bovine diabetogenic proteinG F Tutwiler
Experientia|November 15, 1973
Hypoglycemic activity of alpha-bromopalmitate in ratsG F Tutwiler
Biochemical Medicine|October 1, 1979
Effect of the oral hypoglycemic agent, pirogliride, on lipolysisG F Tutwiler
Biochimica Et Biophysica Acta|September 8, 1975
In vitro lipolytic effect of bovine pituitary diabetogenic proteinG F Tutwiler
Acta Diabetologica Latina|September 1, 1976
Diabetogenic activity of the anterior pituitary (a progress report)G F Tutwiler
Research Communications in Chemical Pathology and Pharmacology|March 1, 1978
Effects of phenformin and alpha-bromopalmitate on fatty acid and glucose oxidation in muscleG F Tutwiler
Comparative Biochemistry and Physiology. A, Comparative Physiology|April 1, 1975
Immunological characterization of a diabetogenic protein from bovine adenohypophysisG F Tutwiler
Biochemistry International|July 1, 1983
Effect of the oral hypoglycemic agent pirogliride (McN-3495) on glycogen levels of normal and diabetic ratsG F Tutwiler, H Fawthrop
The Journal of Biological Chemistry|April 25, 1979
Action of the oral hypoglycemic agent 2-tetradecylglycidic acid on hepatic fatty acid oxidation and gluconeogenesisG F Tutwiler, P Dellevigne
Diabetes|August 1, 1978
Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanidesG F Tutwiler, G Bridi
Pageof 4